Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: MITOCHON PHARMACEUTICALS, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-11-08 to 2025-10-24
Current total value of award: $50000
Description: MP201 DRUG DEVELOPMENT/SYNTHESIS